| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1103128577 |
| P356 | DOI | 10.1186/S13045-018-0595-3 |
| P8608 | Fatcat ID | release_tjfomjwubjgmnkz7et65cesumy |
| P932 | PMC publication ID | 5885466 |
| P698 | PubMed publication ID | 29618368 |
| P50 | author | Weicheng Wu | Q91598433 |
| P2093 | author name string | Jianxin Gu | |
| Jing Wang | |||
| Yilin Wang | |||
| Shushu Song | |||
| Tianxiao Yang | |||
| Lan Fang | |||
| Jiangfan Zhou | |||
| Wenjuan Dai | |||
| Xixi Zheng | |||
| P2860 | cites work | MIF signal transduction initiated by binding to CD74 | Q24303802 |
| CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex | Q24307384 | ||
| Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan | Q24321692 | ||
| Links between metabolism and cancer | Q24626229 | ||
| Inflammation and cancer | Q24649640 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Macrophage migration inhibitory factor: a regulator of innate immunity | Q28204158 | ||
| The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity | Q28295198 | ||
| MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 | ||
| A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc | Q28511795 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites | Q33896841 | ||
| Expression of bisecting N-acetylglucosaminyltransferase-III in human hepatocarcinoma tissues, fetal liver tissues, and hepatoma cell lines of Hep3B and HepG2. | Q34107206 | ||
| A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. | Q50753723 | ||
| Acetoacetate metabolism in AS-30D hepatoma cells. | Q51594509 | ||
| Addicted to AA (Acetoacetate): A Point of Convergence between Metabolism and BRAF Signaling. | Q52307539 | ||
| N-Acetylglucosaminyltransferase V exacerbates murine colitis with macrophage dysfunction and enhances colitic tumorigenesis. | Q53352972 | ||
| The inhibition of malignant cell growth by ketone bodies | Q53580986 | ||
| Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity | Q61772241 | ||
| N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma | Q77792723 | ||
| Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2 | Q79370205 | ||
| Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia | Q34193811 | ||
| The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
| The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase | Q34448866 | ||
| Migration inhibitory factor expression in experimentally induced endotoxemia | Q35765238 | ||
| Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. | Q35825254 | ||
| An Analysis of MIF Structural Features that Control Functional Activation of CD74. | Q36075317 | ||
| Cunning factor: macrophage migration inhibitory factor as a redox-regulated target | Q37015273 | ||
| Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening | Q37187080 | ||
| Alteration of protein glycosylation in liver diseases | Q37373750 | ||
| Inflammation and liver cancer: new molecular links . | Q37403661 | ||
| Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation | Q37594369 | ||
| Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein | Q37618668 | ||
| Decreased expression of STING predicts poor prognosis in patients with gastric cancer | Q37630679 | ||
| Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways | Q37671165 | ||
| Tumor-associated macrophages: from basic research to clinical application | Q37671174 | ||
| Role of tumor-associated macrophages in the progression of hepatocellular carcinoma | Q37960792 | ||
| Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration | Q38320031 | ||
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. | Q38416518 | ||
| Glycosylation in cancer: mechanisms and clinical implications | Q38569702 | ||
| Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor | Q39198190 | ||
| Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer | Q39234566 | ||
| Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor | Q40422713 | ||
| MIF as a glucocorticoid-induced modulator of cytokine production | Q41296855 | ||
| Tumor-associated macrophages, potential targets for cancer treatment. | Q41318642 | ||
| The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages | Q41481421 | ||
| Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. | Q41550485 | ||
| Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V | Q41624754 | ||
| Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. | Q41637048 | ||
| Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma | Q44395085 | ||
| Involvement of B3GALNT2 overexpression in the cell growth of breast cancer | Q44668115 | ||
| Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth | Q47992732 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P304 | page(s) | 50 | |
| P577 | publication date | 2018-04-04 | |
| P1433 | published in | Journal of Hematology & Oncology | Q15724593 |
| P1476 | title | Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity. | |
| P478 | volume | 11 |
| Q93060431 | Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals |
| Q92542015 | Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients |
| Q83600759 | Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention |
Search more.